Letter
Prevention of coronary heart disease
Cite this as:
BMJ
2004;328:404.2
Statins are even less effective than paper shows
- David Taylor, general practitioner principal,
- Arnold Jenkins, general practitioner principal,
- Philipp Conradi, part time general practitioner (pconradi@hotmail.com)
- Birmingham B31 2HZ
- Burnley BB10 1LG
- Birmingham B7 5DT
EDITOR—Marshall commendably questions current trends in preventive medicine.1 He looks at cost effectiveness of cardioprotective drug treatment, including simvastatin 40 mg, by assessing pooled data from different trials. Treatment effects are balanced with costs. The expenditure for simvastatin 40 mg is calculated as prescribing costs plus additional costs for …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking